OIG September 2017 Summary:
“Drug Supply Chain Security: Wholesalers Exchange Most Tracing Information”

The Office of Inspector General (OIG) issued its first in a series of examinations of drug supply chain security that will outline provisions for the implementation the Drug Supply Chain Security Act (DSCSA). This Report Discusses:

  • The Office of Inspector General’s methodology
  • Key findings from the report
  • Recommendations based on The FDA & The OIG’s findings

Want to read the entire article?
Sign up for our monthly newsletters and receive exclusive news, whitepapers, and more about the Pharmaceutical and Healthcare industry!

Name (required)


Email (required)


Company (required)


Title (required)


4 East Bridge Street
New Hope, PA
Monday - Friday
8:00 AM - 5:00 PM